Clinical trial
CARESS in Acute Myocardial Infarction
NCT00220571 · Società Italiana di Cardiologia Invasiva, Other · Completed
Key facts
| NCT number | NCT00220571 |
|---|---|
| Title | CARESS in Acute Myocardial Infarction |
| Official title | Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction |
| Lead sponsor | Società Italiana di Cardiologia Invasiva, Other |
| Collaborators | Royal Brompton & Harefield NHS Foundation Trust Eli Lilly and Company Industry Biotronik SE & Co. KG |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Device |
| Interventions | Coronary Angioplasty (PTCA) |
| Enrollment | 600 |
| Start date | May 1, 2003 |
| Completion | Mar 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 3, 2007 |
| Countries | France, Italy, Poland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: